- Home
- MRNA vs CIB Comparison
MRNA vs CIB Comparison
Compare MRNA & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CIB
- Stock Information
- Founded
- MRNA 2010
- CIB 1945
- Country
- MRNA United States
- CIB Colombia
- Employees
- MRNA N/A
- CIB N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CIB Commercial Banks
- Sector
- MRNA Health Care
- CIB Finance
- Exchange
- MRNA Nasdaq
- CIB Nasdaq
- Market Cap
- MRNA 9.8B
- CIB 10.6B
- IPO Year
- MRNA 2018
- CIB 1995
- Fundamental
- Price
- MRNA $27.89
- CIB $52.61
- Analyst Decision
- MRNA Hold
- CIB Sell
- Analyst Count
- MRNA 17
- CIB 4
- Target Price
- MRNA $42.40
- CIB $42.00
- AVG Volume (30 Days)
- MRNA 12.3M
- CIB 271.3K
- Earning Date
- MRNA 11-06-2025
- CIB 11-06-2025
- Dividend Yield
- MRNA N/A
- CIB 9.21%
- EPS Growth
- MRNA N/A
- CIB 10.77
- EPS
- MRNA N/A
- CIB 1.70
- Revenue
- MRNA $3,078,000,000.00
- CIB $5,776,937,796.00
- Revenue This Year
- MRNA N/A
- CIB $30.39
- Revenue Next Year
- MRNA $9.75
- CIB $5.80
- P/E Ratio
- MRNA N/A
- CIB $8.47
- Revenue Growth
- MRNA N/A
- CIB 11.56
- 52 Week Low
- MRNA $23.15
- CIB $30.65
- 52 Week High
- MRNA $59.73
- CIB $53.99
- Technical
- Relative Strength Index (RSI)
- MRNA 58.77
- CIB 59.95
- Support Level
- MRNA $26.91
- CIB $51.57
- Resistance Level
- MRNA $28.99
- CIB $52.49
- Average True Range (ATR)
- MRNA 1.22
- CIB 0.87
- MACD
- MRNA 0.35
- CIB -0.15
- Stochastic Oscillator
- MRNA 76.78
- CIB 65.22
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.